Δ4-3-Oxosteroid 5β-reductase deficiency: Failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid

Gut

Volumn 38, Issue 4, 1996, Pages 623-628

  Clayton, P T ^a   Mills, K A ^a   Johnson, A W ^a   Barabino, A ^b   Marazzi, M G ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Bile acid synthesis; Cholestasis; Giant cell hepatitis; Inborn error

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; STEROID REDUCTASE;

ARTICLE; CASE REPORT; CHOLESTASIS; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HUMAN; INFANT; LIVER DISEASE; PRIORITY JOURNAL;

EID: 0030007164     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.4.623     Document Type: Article

References (23)

1. Clayton PT. Inborn errors of bile acid synthesis. In: Fernandes J, Saudubray J-M, van den Berghe G, eds. Inborn metabolic diseases. Diagnosis and Treatment. Berlin: Springer-Verlag, 1995: 341-8.
2. Clayton PT, Casteels M, Mieli-Vergani G, Lawson AM. Familial giant cell hepatitis with low bile acid concentrations and increased urinary excretion of specific bile alcohols. A new inborn error of bile acid synthesis? Pediatr Res 1995; 37: 424-31.
3. Lawson AM, Madigan MJ, Shortland DB, Clayton PT. Rapid diagnosis of Zellweger syndrome and infantile Refsum disease by fast atom bombardment of urine bile salts. Clin Chim Acta 1986; 161: 221-31.
4. Clayton PT, Leonard JV, Lawson AM, Setchell KDR, Andersson S, Egestad B, et al. Familial giant cell hepatitis associated with synthesis of 3β,7α-dihydroxy-and 3β,7α, 12α-trihydroxy-5-cholenoic acids. J Clin Invest 1987; 79: 1031-8.
5. Clayton PT, Patel F, Lawson AM, Carruthers RA, Tanner MS, Strandvik B, et al. 3-Oxo-delta-4 bile acids in liver disease [Letter]. Lancet 1988; i: 1283-4.
6. Clayton PT. Bile acid metabolism in children with hepatobiliary disease. International Pediatrics 1995; 10: 44-50.
7. 4-3-Oxosteroid 5β-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis. J Clin Invest 1988; 82: 2148-57.
8. 4-3-Oxosteroid 5β-reductase deficiency causing neonatal liver failure and neonatal hemochromatosis. J Pediatr 1994; 124: 234-8.
9. 4-3-oxosteroid 5β-reductase deficiency and neonatal hemochromatosis [Letter]. J Pediatr 1994; 125: 845-6.
10. 4-3-Oxosteroid 5β-reductase deficiency and neonatal hemochromatosis. Reply [Letter]. J Pediatr 1994; 125: 846.
11. 4-3-oxosteroid 5β-reductase deficiency). Hepatology 1993; 18: 1096-101.
12. Setchell KDR, Lawson AM. Bile acids. In: Lawson AM, ed. Mass spectrometry. Berlin: Walter de Gruyter, 1989; 55-109.
13. Clayton PT, Muller DPR. A simplified gas-liquid chromatographic method for the estimation of non-sulphated plasma bile acids. Clin Chim Acta 1980; 105: 401-5.
14. Clayton PT, Lake BD, Hall NA, Shortland DB, Carruthers RA, Lawson AM. Plasma bile acids in patients with peroxisomal dysfunction syndromes; analysis by capillary gas chromatography - mass spectrometry. Eur J Pediatr 1987; 146: 166-73.
15. Clayton PT, Bowron A, Mills KA, Masoud A, Casteels M, Milla PJ. Phytosterolaemia in children with patenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993; 105: 1806-13.
16. Sjövall J. Mass spectrometry in studies of inherited and acquired diseases of bile acid synthesis and metabolism. In: Matsumoto I, Kuhara T, Mamer OA, Sweetman L, Calderhead RG, eds. Advances in chemical diagnosis and treatment of metabolic disorders. Vol 2. Kanazawa: Kanazawa Medical University Press, 1994: 107-22.
17. Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Kruizinga W. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid. Biochim Biophys Acta 1987; 917: 238-46.
18. 4-3-Oxosteroid 5β-reductase and substrate specificity of the expressed enzyme. Eur J Biochem 1994; 219: 357-63.
19. 27-steroid dehydrogenase/isomerase deficiency. J Pediatr 1994; 125: 379-84.
20. 27-steroid dehydrogenase deficiency with chenodeoxycholic acid. Arch Dis Child 1990; 65: 1121-4.
21. 27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment. J Lipid Res 1991; 32: 829-41.
22. Stieger B, Zhang J, O'Neill B, Sjövall J, Meier PJ. Transport of taurine conjugates of 7α-hydroxy-3-oxo-4-cholenoic acid and 3β,7α-dihydroxy-5-cholenoic acid in rat liver plasma membrane vesicles. In: van Berge Henegouwen, et al, eds. Cholestatic liver diseases. Dordrecht: Kluwer Academic, 1994: 82-7.
23. Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Waterreus RJ, Oosterhuis HGJGH. Capillary gas chromatographic determinations or urinary bile acids and bile alcohols in CTX-patients proving the ineffectivity of ursodeoxycholic acid treatment. Clin Chim Acta 1984; 142: 103-11.